Cargando…
Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma
Ipilimumab and nivolumab are immune checkpoint inhibitors that have recently been used in the treatment of metastatic melanoma and other cancers. Immune-mediated colitis is one of their adverse events that need to be differentiated from low-grade diarrhea as one of the most common side effects. A 51...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112207/ https://www.ncbi.nlm.nih.gov/pubmed/33987063 http://dx.doi.org/10.7759/cureus.14414 |